Unlocking chemical matter on scale

webinar

Tue, 07 Jul 2020, 17:00 CEST (Berlin)

Dr. Serghei Glinca, CEO Crystals First GmbH, Marburg, Germany

Unlocking chemical matter on scale

Fragment-based lead discovery (FBLD) has undoubtedly become an invaluable resource for medicinal chemists in the identification of lead candidates.

Since an efficient fragment evolution requires structural data of protein-ligand interactions, a variety of biophysical methods are applied in a cascade approach as a set of prefilter prior to structure determination. Systematic studies suggest that the cascade approach significantly reduces the hit rate compared to a direct crystallographic screening.

The application of X-ray crystallography as a primary fragment screening method has been underutilized due to the limited availability of a robust system for soaking experiments and solubility issues of fragments. One of major bottlenecks in the experimental setup for crystal soaking is the sensitivity of protein crystals. We overcome this limitation using the SmartSoak® technology, which stabilizes protein crystals leading to high-performance soaking systems. No trial-and-error optimization of the soaking system needed.

In case studies, we demonstrate the advantages of the application of crystallographic fragment screening as a primary screening strategy for the hit identification. The resulting structural data can now be utilized to explore the chemical space on scale using computational methods.

Current news

category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on
CORE by Onepot.AI – Access now with our tools
October 27, 2026 14:38 CET
Bringing Robotic Synthesis to Chemical Space Exploration A new Chemical Space is now available for your compound exploration: onepot’s CORE Space brings over 10 billion virtual product molecules to your drug discovery projects. CORE (Compounds On-demand via Robotic Execution) combines reactions widely used in medicinal chemistry with building blocks that...
Read on
A Milestone with Our Pioneering Partner: REAL Space Crosses 100 Billion
October 14, 2026 13:51 CEST
Crossing the 100 Billion Mark REAL Space has entered the 100+ billion era. The October update brings Enamine’s Chemical Space to 113,699,103,092 virtual product molecules, opening up an even larger collection of make-on-demand chemistry for your drug discovery projects. Built from 211,806 building blocks and 161 chemical reactions, implemented as...
Read on